Science Daily -
17 Sep 2016 21:23
An ingenious way to spur checkpoint blockade cancer immunotherapy into more potent action has been developed by a group of researchers. The therapy offers the hope of an effective treatment for intractable metastatic cancers including those of the colon and lung.
Share this Article